RegMed Daily, Closing Bell, 4/4/12, big down day with slow comeback as NASDAQ and momentum deteriorate, sustainability is suspect
EOD Commentary: RegMed stocks dive downward … giving back all and any chunks of their gains from the past 3 months, but I expect a … larger pullback in our universe as confidence, visibility and viability in the markets deteriorate.
Closing Bell: The NASDAQ closed DOWN -45.48 (-1.46%) to 3,068.09. The Dow closed DOWN -124.72 (-0.94%) to 13,074.83.
Who’s up … at the close:
- Athersys (ATHX) +$0.04 <+2.61%> to $1.99;
- BioMimetic (BMTI) +$0.21 <+7.78%> to $2.91;
- Fibrocell (OTC BB: FCSC) +$0.02 <+6.45%> to $0.33;
- Neuralstem (Amex: CUR) +$0.01 <+0.88%> to $1.15;
- ReNeuron (RENE.L) +$0.25 <+5.88%> to $4.50;
- StemCells (STEM) +$0.02 <+2.15%> to $0.95.
Related Posts
Categories: RegMed Daily Closing Bell
![50194787B[1]](http://www.scimitarequity.com/blog/wp-content/uploads/50194787B1-e1307466532356.jpg)






